Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Delta-9-Tetrahydrocannabinol Market by Type (Purity 98%, Purity 99%), By Application (Pharmaceutical Industry, Research Organization, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Delta-9-Tetrahydrocannabinol Market by Type (Purity 98%, Purity 99%), By Application (Pharmaceutical Industry, Research Organization, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 369651 4200 Chemical & Material 377 166 Pages 4.7 (33)
                                          

Market Overview:


Purity 99% is expected to account for a larger share of the market during the forecast period. Pharmaceutical industry is expected to account for a larger share of the market duringthe forecast period.


Global Delta-9-Tetrahydrocannabinol Industry Outlook


Product Definition:


It is responsible for the euphoric and mind-altering effects of marijuana. THC is believed to play a role in pain relief, appetite stimulation, and other medicinal effects of cannabis.


Purity 98%:


The product is considered to be the most potent form of THC. It also has higher binding affinity to cannabinoid receptors compared to other forms of the drug.


Purity 99%:


Purity 99% is a type of Pharmaceutical-grade Cannabidiol (CBD) oil that contains less than 0.1% THC, making it extremely pure and effective for specific medical applications. It has been used to treat pain, anxiety, stress and sleep disorders among other health conditions.


Application Insights:


Based on application, the global market is segmented into pharmaceutical industry, research organization and others. The pharmaceutical industry dominated the market in 2017 owing to increasing usage of dronabinol and other synthetic cannabinoids for treating chronic pain. Moreover, rising awareness about treatment options such as opiates that are less addictive compared to heroin is expected to boost demand over the forecast period.


Furthermore, increasing R&D investments by various organizations are expected to propel growth over the coming years. For instance, GW Pharmaceuticals has invested around USD 120 million from 2014 - 2016 on Sativex clinical trials program for treating cancer pain unresponsiveto opioid therapy with minimal side effects.


Regional Analysis:


North America dominated the market in terms of demand with a revenue share of around 60% in 2017. This can be attributed to presence of large number of cannabis users, coupled with higher per capita income and availability of advanced healthcare facilities. Moreover, legalization and implementation of comprehensive regulatory framework pertaining to cannabis cultivation and usage are further expected to drive the market over the forecast period.


Asia Pacific is anticipated to witness fastest growth during the forecast period owing to factors such as increasing use by medical practitioners for treating pain, inflammation & arthritis; mental health issues; sleep disorders; and other conditions associated with anxiety or stress that result in insomnia or wakefulness respectively (known as REM behavior disorder).


Growth Factors:


  • Increasing legalization of medical marijuana: The global market for medical marijuana is expected to grow at a CAGR of 34.8% from 2016 to 2021. This is largely due to the increasing legalization of medical marijuana across the globe. As more and more countries legalize the use of medical marijuana, the market for Delta-9-Tetrahydrocannabinol is expected to grow significantly.
  • Growing awareness about the benefits of cannabis: There is growing awareness about the benefits of cannabis, especially its medicinal properties. This has led to an increase in demand for products that contain Delta-9-Tetrahydrocannabinol, such as CBD oil and edibles.
  • Rising popularity of cannabis among millennials: A study by Yahoo! Finance revealed that millennials are increasingly turning towards cannabis as an alternative investment option . This rising popularity is likely to drive growth in the Delta-9-Tetrahydrocannabinol market in years to come.

Scope Of The Report

Report Attributes

Report Details

Report Title

Delta-9-Tetrahydrocannabinol Market Research Report

By Type

Purity 98%, Purity 99%

By Application

Pharmaceutical Industry, Research Organization, Others

By Companies

Cayman Chemical, Bio-Techne, Canopy Growth, Noramco, KinetoChem, Aphios, Benuvia

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

166

Number of Tables & Figures

117

Customization Available

Yes, the report can be customized as per your need.


Global Delta-9-Tetrahydrocannabinol Market Report Segments:

The global Delta-9-Tetrahydrocannabinol market is segmented on the basis of:

Types

Purity 98%, Purity 99%

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Pharmaceutical Industry, Research Organization, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Cayman Chemical
  2. Bio-Techne
  3. Canopy Growth
  4. Noramco
  5. KinetoChem
  6. Aphios
  7. Benuvia

Global Delta-9-Tetrahydrocannabinol Market Overview


Highlights of The Delta-9-Tetrahydrocannabinol Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Purity 98%
    2. Purity 99%
  1. By Application:

    1. Pharmaceutical Industry
    2. Research Organization
    3. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Delta-9-Tetrahydrocannabinol Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Delta-9-Tetrahydrocannabinol Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Delta-9-tetrahydrocannabinol, or THC, is the primary psychoactive compound in cannabis. It is responsible for causing marijuana's "high."

Some of the key players operating in the delta-9-tetrahydrocannabinol market are Cayman Chemical, Bio-Techne, Canopy Growth, Noramco, KinetoChem, Aphios, Benuvia.

The delta-9-tetrahydrocannabinol market is expected to register a CAGR of 34.8%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Delta-9-Tetrahydrocannabinol Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Delta-9-Tetrahydrocannabinol Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Delta-9-Tetrahydrocannabinol Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Delta-9-Tetrahydrocannabinol Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Delta-9-Tetrahydrocannabinol Market Size & Forecast, 2020-2028       4.5.1 Delta-9-Tetrahydrocannabinol Market Size and Y-o-Y Growth       4.5.2 Delta-9-Tetrahydrocannabinol Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Purity 98%
      5.2.2 Purity 99%
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Pharmaceutical Industry
      6.2.2 Research Organization
      6.2.3 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Delta-9-Tetrahydrocannabinol Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Delta-9-Tetrahydrocannabinol Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Purity 98%
      9.6.2 Purity 99%
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Pharmaceutical Industry
      9.10.2 Research Organization
      9.10.3 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Purity 98%
      10.6.2 Purity 99%
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Pharmaceutical Industry
      10.10.2 Research Organization
      10.10.3 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Purity 98%
      11.6.2 Purity 99%
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Pharmaceutical Industry
      11.10.2 Research Organization
      11.10.3 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Purity 98%
      12.6.2 Purity 99%
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Pharmaceutical Industry
      12.10.2 Research Organization
      12.10.3 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Purity 98%
      13.6.2 Purity 99%
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Pharmaceutical Industry
      13.10.2 Research Organization
      13.10.3 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Delta-9-Tetrahydrocannabinol Market: Competitive Dashboard
   14.2 Global Delta-9-Tetrahydrocannabinol Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Cayman Chemical
      14.3.2 Bio-Techne
      14.3.3 Canopy Growth
      14.3.4 Noramco
      14.3.5 KinetoChem
      14.3.6 Aphios
      14.3.7 Benuvia

Our Trusted Clients

Contact Us